E09.359
Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy without macular edema
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code E09.359 refers to a specific form of diabetes mellitus caused by medication or chemical exposure, which is complicated by proliferative diabetic retinopathy. This condition occurs when prolonged high blood sugar levels damage the blood vessels in the retina, leading to abnormal growth of new blood vessels. Unlike typical diabetic retinopathy, this form is directly linked to the use of certain medications or chemicals known to influence blood sugar regulation and ocular health. Recognizing the connections between drug exposure and eye health is important for managing this condition effectively.
Causes & Symptoms
Clinical Causes: Use of specific medications known to impact glucose metabolism, such as certain diuretics, corticosteroids, or antipsychotics Exposure to harmful chemicals or toxins that interfere with insulin function or blood sugar levels Pre-existing risk factors like obesity, inactive lifestyle, or genetic predisposition that exacerbate drug effects
Key Symptoms: Vision changes such as blurred or distorted vision Seeing floaters or spots in the visual field Darkening or loss of vision in certain areas Eye discomfort or redness Increased floaters or flashes of light indicating retinal changes Possible sudden vision loss if proliferative retinopathy advances
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a comprehensive eye exam, including dilated retinal examination to identify abnormal blood vessel growth. Medical history review focuses on recent medications or chemical exposures associated with hyperglycemia. Blood tests to measure blood sugar levels, hemoglobin A1c, and other indicators of diabetic control are essential. Imaging studies like retinal photography or fluoroangiography may be used to assess the severity of retinopathy and identify proliferative changes.
Treatment Protocols: Management strategies include controlling blood sugar levels through medications, lifestyle adjustments, and monitoring. Specific eye treatments for proliferative diabetic retinopathy may involve laser therapy to reduce abnormal vessel growth, intravitreal injections of anti-VEGF agents, or vitrectomy in advanced cases. Addressing the underlying cause of drug or chemical exposure is crucial to prevent progression. Regular visual and blood sugar monitoring are recommended to detect early signs of complications and tailor treatment plans accordingly.
Clinical Advice & FAQs
Billing Guidance
Is E09.359 a billable ICD-10 code?
Yes, E09.359 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E09.359?
Clinical documentation must specify the nature of Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy without macular edema and any associated comorbidities for accurate reporting.
Cite this Clinical Reference